Springhill Bioventures

Springhill Bioventures is a healthcare-focused venture capital firm headquartered in Suzhou, China, with additional operations in Shanghai. Founded in 2020 by Dr. Shidong Jiang, a veteran of WuXi AppTec and Eli Lilly, the firm specializes in early-stage investments across the life sciences spectrum, including innovative therapeutics, medical devices, and diagnostics. Springhill Bioventures aims to bridge the gap between scientific innovation and commercial success by providing both capital and strategic operational support to its portfolio companies. The firm leverages its deep industry network and technical expertise to identify and nurture high-potential startups in the biotechnology and healthcare industries. Its investment strategy emphasizes scientific rigor and the potential for global commercialization of Chinese-originated innovations.